Phosphaturic Mesenchymal Tumors: Histologic Mimics and Updates

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Phosphaturic mesenchymal tumor (PMT) is a rare bone and soft tissue neoplasm.
• PMTs induce tumor-induced osteomalacia via phosphatonins, primarily FGF23.
• Distinctive histologic features include spindled cells, vascular stroma, calcified matrix, and giant cells.

Purpose of the Study:

• To review the clinical, histologic, immunohistochemical, and molecular genetic characteristics of PMTs.
• To discuss potential therapeutic strategies for PMTs.
• To differentiate PMTs from other similar-appearing tumors.

Main Methods:

• Literature review of clinical, histologic, immunohistochemical, and molecular genetic studies on PMTs.
• Analysis of diagnostic criteria and differential diagnoses.
• Synthesis of current understanding of PMT pathogenesis and treatment.

Main Results:

• PMT pathogenesis involves FGFR1 pathway activation, through FN1::FGFR1/FGF1 fusions or alpha-Klotho overexpression.
• FGFR1 pathway dysregulation drives both tumorigenesis and FGF23 overproduction.
• Histologic features are characteristic but require molecular confirmation.

Conclusions:

• PMTs are characterized by specific genetic alterations affecting the FGFR1 pathway.
• Understanding these molecular mechanisms is crucial for accurate diagnosis and targeted therapy.
• Further research is needed to optimize treatment strategies for PMTs.